Eye Drops for Newborn Infants
For neonatal ocular prophylaxis, erythromycin 0.5% ophthalmic ointment should be applied to each eye in a single application at birth to prevent gonococcal ophthalmia neonatorum 1, 2.
Prophylaxis at Birth
The 2024 AAO Conjunctivitis Preferred Practice Pattern and USPSTF guidelines establish clear standards for universal prophylaxis:
- Erythromycin 0.5% ophthalmic ointment is the only FDA-approved agent for neonatal ocular prophylaxis in the United States 1, 2
- Apply once to each eye immediately after birth
- This prevents gonococcal ophthalmia neonatorum, which can cause corneal scarring, perforation, and blindness 2
- The USPSTF concludes with high certainty that benefits substantially outweigh harms 2
Important caveat: While erythromycin prophylaxis is standard practice and mandated in most U.S. states, recent evidence suggests it may be ineffective against chlamydial conjunctivitis and increasingly resistant gonococcal strains 3. However, given current guidelines and FDA approval, it remains the recommended agent until official recommendations change.
Alternative agents mentioned in guidelines but not FDA-approved in the U.S. include 2.5% povidone-iodine solution 1, 2.
Treatment of Neonatal Conjunctivitis
When conjunctivitis develops despite prophylaxis, treatment depends on the causative organism:
Gonococcal Conjunctivitis (Ophthalmia Neonatorum)
Systemic treatment is mandatory - topical therapy alone is insufficient 1, 4:
- Ceftriaxone 25-50 mg/kg IV or IM (single dose, not exceeding 250 mg) 1
- Alternative: Cefotaxime 100 mg/kg IV or IM (single dose) 1
- Presents within 1-7 days of birth with marked lid edema, purulent discharge, and risk of corneal perforation 1
- Parents must also be treated for gonorrhea 4
Chlamydial Conjunctivitis
Systemic antibiotics are required - topical therapy is inadequate 1, 4:
- Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into 4 doses for 14 days 1
- Alternative: Azithromycin suspension 20 mg/kg/day orally once daily for 3 days 1
- Manifests 5-19 days after birth with mucopurulent or blood-stained discharge 1
- Up to 50% have associated nasopharyngeal or pulmonary infection 1
- Mothers and sexual partners require treatment 4
Other Bacterial Conjunctivitis
Most non-gonococcal, non-chlamydial bacterial conjunctivitis can be treated with topical antibiotics 4, 5:
- Broad-spectrum topical antibiotics (e.g., polymyxin B-trimethoprim, fluoroquinolones)
- Exception: Pseudomonas infection requires systemic therapy 4
- Follow-up is essential to ensure resolution 4
Viral Conjunctivitis
- Artificial tears
- Cold compresses
- Topical antihistamines for symptom relief
- No specific antiviral treatment for most cases
- Strict hand hygiene to prevent transmission 6
Allergic Conjunctivitis
Topical antihistamines with mast cell-stabilizing activity are first-line 5, 6:
- Itching is the hallmark symptom distinguishing allergic from infectious causes 5, 6
- Dual-action agents (antihistamine + mast cell stabilizer) preferred
Critical Diagnostic Considerations
When evaluating neonatal conjunctivitis:
- Obtain conjunctival swab for Gram stain and culture before starting treatment 4
- If Gram-negative diplococci present: treat immediately for presumed gonorrhea 4
- Timing of onset helps differentiate causes:
- 1-7 days: gonococcal
- 5-19 days: chlamydial
- Earlier presentations possible with premature membrane rupture 1
Red Flags Requiring Immediate Ophthalmology Referral
- Corneal infiltrate or ulcer (risk of perforation) 1
- Severe purulent discharge with lid edema
- Any neonate with conjunctivitis and systemic signs 6
- Vesicular rash on eyelids (herpes simplex)
The key principle: Gonococcal and chlamydial neonatal conjunctivitis always require systemic antibiotics, not just topical therapy, due to risk of systemic infection and treatment failure with topical agents alone.